F. Augustovski
Statistics and Probability · 2013–2022
A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 36 citations into it
Whom F. Augustovski trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Douglas G. Altman (in Statistics and Probability)
- David Moher (in Statistics and Probability)
Papers from F. Augustovski's perspective
Ordered by how strongly the researchers F. Augustovski trusts endorse each paper. Same corpus, a different order for every researcher.
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (British medical journal)
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (British medical journal)
- CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials (Obstetrics and Gynecology)
- Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. (Value in Health)
- Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses (British medical journal)
- Guidance for Developers of Health Research Reporting Guidelines (PLoS Medicine)
- The estimation of a preference-based measure of health from the SF-36. (Journal of Health Economics)
- Subgroup analysis and other (mis)uses of baseline data in clinical trials.
- Cost-Effectiveness of Interventions to Promote Physical Activity: A Modelling Study (PLoS Medicine)
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. (The Lancet)
Their papers
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. (2022) — 647 citations
- Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations (2022) — 1,522 citations
- Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. (2015) — 705 citations
- Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. (2014) — 1,014 citations
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. (2013) — 1,835 citations
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013) — 2,158 citations